ROCHESTER, N.Y., Jan. 28, 2011 /PRNewswire/ — VirtualScopics,
Inc. (Nasdaq:
VSCP), a leading provider of quantitative imaging for clinical
trials, today announced that before the market opens on Thursday,
February 24, 2011 it will release its fourth quarter and full year
2010 financial results. The company will host a conference call
that morning at 11:00 a.m. EST.
VirtualScopics’ President and Chief Executive Officer, Jeff
Markin, and Chief Business and Financial Officer, Molly Henderson,
will provide a business update and discuss the company’s results
for the quarter and year ended December 31, 2010 during the
conference call.
Interested participants should call 877-407-8035 when calling
within the United States or 201-689-8035 when calling
internationally. This call can also be accessed at www.virtualscopics.com
and will be available for 30 days after the call.
About VirtualScopics, Inc.VirtualScopics, Inc. is a leading
provider of imaging solutions to accelerate drug and medical device
development. VirtualScopics has developed a robust software
platform for analysis and modeling of both structural and
functional medical images. In combination with
VirtualScopics’ industry-leading experience and expertise in
advanced imaging biomarker measurement, this platform provides a
uniquely clear window into the biological activity of drugs and
devices in clinical trial patients, allowing sponsors to make
better decisions faster. For more information about
VirtualScopics, visit www.virtualscopics.com.
Forward-Looking Statements The statements contained in this
press release that are not purely historical are forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933, as amended and Section 21E of the Securities
‘/>”/>
